These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6670053)

  • 21. [Use of clonidine in the treatment of morphine withdrawal syndrome: neuropharmacological bases and clinical application].
    Gurpegui M; Sweeney DR; Gold MS
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1983; 11(3):253-8. PubMed ID: 6687343
    [No Abstract]   [Full Text] [Related]  

  • 22. The Key Extended Entry Program (KEEP): from the community side of the bridge.
    Fallon BM
    Mt Sinai J Med; 2001 Jan; 68(1):21-7. PubMed ID: 11135502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ambulatory medical treatment of drug dependent patients].
    Gölz J
    Z Arztl Fortbild (Jena); 1996 Jun; 90(4):271-8. PubMed ID: 8928526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Can substitution practices be indicated in withdrawal programs for heroin addicts?].
    Boissonnas A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():96-7. PubMed ID: 7880042
    [No Abstract]   [Full Text] [Related]  

  • 26. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions.
    Kipnis SS; Herron A; Perez J; Joseph H
    Mt Sinai J Med; 2001 Jan; 68(1):28-32. PubMed ID: 11135503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Maintenance" treatment of addiction: to whose credit, and why it matters.
    Newman RG
    Int J Drug Policy; 2009 Jan; 20(1):1-3. PubMed ID: 18775657
    [No Abstract]   [Full Text] [Related]  

  • 29. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of drug dependent patients with methadone. 1: Goals, types and results of methadone programs].
    Böcker FM
    Fortschr Med; 1991 Feb; 109(5):129-31. PubMed ID: 2045034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.
    Gold MS; Redmond DE; Kleber HD
    Am J Psychiatry; 1979 Jan; 136(1):100-2. PubMed ID: 364997
    [No Abstract]   [Full Text] [Related]  

  • 33. [Methadone, clonidine and levomepromazine in the treatment of opiate abstinence syndrome: double-blind clinical trial in heroin-addicted patients admitted to a general hospital for organic pathology].
    Vilalta J; Treserra J; García-Esteve L; García-Giralt M; Cirera E
    Med Clin (Barc); 1987 May; 88(17):674-6. PubMed ID: 3613695
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS; Gordon M; Pachter IJ
    Proc Natl Conf Methadone Treat; 1973; 2():1336-41. PubMed ID: 4215978
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary evaluation of methadone program in Kraków].
    Kamenczak A; Chrostek Maj J; Kroch S; Groszek B
    Przegl Lek; 2000; 57(10):525-30. PubMed ID: 11199879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhabdomyolysis and brain ischemic stroke in a heroin-dependent male under methadone maintenance therapy.
    Hsu WY; Chiu NY; Liao YC
    Acta Psychiatr Scand; 2009 Jul; 120(1):76-9. PubMed ID: 19392810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach].
    Presslich O; Loimer N; Aschauer G; Fodor G; Pfersmann D; Müller K; Pakesch G; Lieber A
    Psychiatr Prax; 1989 Sep; 16(5):179-81. PubMed ID: 2798589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.